DJ Amgen Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ slipped 1.52% to $340.16 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.11% to 6,857.12 and the Dow Jones Industrial Average falling 0.07% to 47,850.94.
The stock's fall snapped a two-day winning streak.
Amgen Inc. closed 1.80% below its 52-week high of $346.38, which the company achieved on December 3rd.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 1.39% to $202.48, Pfizer Inc. $(PFE)$ rose 0.51% to $25.70, and AbbVie Inc. $(ABBV)$ fell 0.66% to $228.71.
Trading volume (3.4 M) eclipsed its 50-day average volume of 2.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 4, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 04, 2025 16:35 ET (21:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments